Jonathan I. Lieber, Chief Financial Officer at HISTOGENICS CORP (HSGX), bought 5,000 shares at $1.95 ($10K) on 2016-12-02, disclosed to the SEC on 2016-12-02.
Open-market purchase of $10k HSGX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| RLYB | BUY | 2023-03-16 | $26K | — | Filing → |
| SLRX | BUY | 2022-06-08 | $7K | — | Filing → |
| ALTU | SELL | 2007-12-18 | $18K | — | Filing → |